M. A. Yurlova
M. A. Yurlova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alexander O. Vasilyev
Russian University of Medicine, Ministry of Health of Russia
1 shared publication - Alexander V. Govorov
Russian University of Medicine, Ministry of Health of Russia
1 shared publication - Andemirkan Yu. Borukaev
Vishnevsky National Medical Research Center of Surgery
1 shared publication - Dmitrii Yu. Pushkar
Russian University of Medicine, Ministry of Health of Russia; S. P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
1 shared publication - Dmitry Mikhailivich Monakov
A.V. Vishnevsky National Medical Research Center of Surgery
1 shared publication - F. A. Medvedev
Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department; Russian University of Medicine, Ministry of Health of Russia; S. P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
1 shared publication
Latest Publications
- Open Access
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 67-80
The role of arterial hypertension and antihypertensive therapy in planning nerve-sparing prostatectomy: impact on erectile function
Assessment of erectile function in patients with prostate cancer is essential when planning nerve-sparing radical prostatectomy. However, reliance solely on validated questionnaires may result in biased estimates because of the subjective nature of self-assessment and the psychological impact of a cancer diagnosis. Therefore, comparing questionnairebased findings with objective methods of erectile function assessment and evaluating factors that may influence erectile function, including arterial hypertension and antihypertensive therapy, is clinically important. Purpose of the study . To evaluate preoperative erectile function in patients with low- and intermediate-risk prostate cancer scheduled for robot-assisted nerve-sparing radical prostatectomy and to assess the impact of hypertension, hypertension grade, and antihypertensive therapy on erectile function. Patients and methods . This prospective study included 150 patients with prostate cancer. Erectile function was assessed using the International Index of Erectile Function‑5 (IIEF‑5), the Erection Hardness Score (EHS), the Sexual Encounter Profile (SEP), and nocturnal penile tumescence (NPT) monitoring with the Androscan MIT device. Statistical analysis was performed using StatTech version 4.13.0. Results . The presence of hypertension was significantly associated with a greater severity of erectile dysfunction (ED), as assessed both by IIEF‑5 (p = 0.030) and NPT data (p = 0.023). The stage of hypertension and the grade of arterial hypertension were associated with deterioration of objective NPT parameters (p = 0.047 and p = 0.031, respectively). Among antihypertensive medications, the use of ACE inhibitors/angiotensin receptor blockers (ARBs), calcium channel blockers, and diuretics (predominantly indapamide) was associated with a significant reduction in NPT duration; statins, classified separately as lipid-lowering rather than antihypertensive therapy, showed no significant association. ED severity categories assigned by IIEF‑5 and by Androscan did not match in 62.2 % of cases. Conclusion . Arterial hypertension is an independent preoperative risk factor for erectile dysfunction in patients with prostate cancer. Objective NPT monitoring identifies a substantially higher prevalence of erectile function impairment compared with self-assessment using the IIEF‑5. These findings may be useful in selecting candidates for nerve-sparing prostatectomy.
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 67-80
Open AccessThe role of arterial hypertension and antihypertensive therapy in planning nerve-sparing prostatectomy: impact on erectile function
Assessment of erectile function in patients with prostate cancer is essential when planning nerve-sparing radical prostatectomy. However, reliance solely on validated questionnaires may result in biased estimates because of the subjective nature of self-assessment and the psychological impact of a cancer diagnosis. Therefore, comparing questionnairebased findings with objective methods of erectile function assessment and evaluating factors that may influence erectile function, including arterial hypertension and antihypertensive therapy, is clinically important. Purpose of the study . To evaluate preoperative erectile function in patients with low- and intermediate-risk prostate cancer scheduled for robot-assisted nerve-sparing radical prostatectomy and to assess the impact of hypertension, hypertension grade, and antihypertensive therapy on erectile function. Patients and methods . This prospective study included 150 patients with prostate cancer. Erectile function was assessed using the International Index of Erectile Function‑5 (IIEF‑5), the Erection Hardness Score (EHS), the Sexual Encounter Profile (SEP), and nocturnal penile tumescence (NPT) monitoring with the Androscan MIT device. Statistical analysis was performed using StatTech version 4.13.0. Results . The presence of hypertension was significantly associated with a greater severity of erectile dysfunction (ED), as assessed both by IIEF‑5 (p = 0.030) and NPT data (p = 0.023). The stage of hypertension and the grade of arterial hypertension were associated with deterioration of objective NPT parameters (p = 0.047 and p = 0.031, respectively). Among antihypertensive medications, the use of ACE inhibitors/angiotensin receptor blockers (ARBs), calcium channel blockers, and diuretics (predominantly indapamide) was associated with a significant reduction in NPT duration; statins, classified separately as lipid-lowering rather than antihypertensive therapy, showed no significant association. ED severity categories assigned by IIEF‑5 and by Androscan did not match in 62.2 % of cases. Conclusion . Arterial hypertension is an independent preoperative risk factor for erectile dysfunction in patients with prostate cancer. Objective NPT monitoring identifies a substantially higher prevalence of erectile function impairment compared with self-assessment using the IIEF‑5. These findings may be useful in selecting candidates for nerve-sparing prostatectomy.
- Open Access
- 29 June 2026
- Published by "MedINK" Publishing House in Academy for Practical Oncology
- Vol. 1 (1) , 40-47
Robot-assisted surgery: is there a role for artificial intelligence?
Robotic surgery (RS) is considered a stage in the evolution of minimally invasive procedures. Despite the increasing adoption of RS, challenges remain regarding outcome reproducibility, pronounced operator dependence, learning curves, and technological and organizational constraints, which underscores the need to further develop the “digital layer” of surgery and to apply artificial intelligence (AI) for intraoperative data analysis. A systematic literature review was conducted using Russianand English-language keywords related to RS and AI. The review summarizes key directions of AI integration into robot-assisted procedures, most commonly implemented as modules for surgical video and instrument kinematic analysis, including computer vision, phase and task recognition, extraction of objective performance metrics, automated skill assessment and training support, predictive modeling of selected postoperative course parameters, and elements of partial automation of subtasks while maintaining the primacy of clinical oversight. The interpretation of published results is limited by heterogeneity in datasets and evaluation protocols, as well as differences in annotation strategies, performance metrics, and validation approaches, which complicates crossstudy comparisons and model transferability across institutions. Clinical implementation of AI is further associated with requirements for data privacy and security, cyber-resilience, model transparency, and regulatory accountability.
- 29 June 2026
- Published by "MedINK" Publishing House in Academy for Practical Oncology
- Vol. 1 (1) , 40-47
Open AccessRobot-assisted surgery: is there a role for artificial intelligence?
Robotic surgery (RS) is considered a stage in the evolution of minimally invasive procedures. Despite the increasing adoption of RS, challenges remain regarding outcome reproducibility, pronounced operator dependence, learning curves, and technological and organizational constraints, which underscores the need to further develop the “digital layer” of surgery and to apply artificial intelligence (AI) for intraoperative data analysis. A systematic literature review was conducted using Russianand English-language keywords related to RS and AI. The review summarizes key directions of AI integration into robot-assisted procedures, most commonly implemented as modules for surgical video and instrument kinematic analysis, including computer vision, phase and task recognition, extraction of objective performance metrics, automated skill assessment and training support, predictive modeling of selected postoperative course parameters, and elements of partial automation of subtasks while maintaining the primacy of clinical oversight. The interpretation of published results is limited by heterogeneity in datasets and evaluation protocols, as well as differences in annotation strategies, performance metrics, and validation approaches, which complicates crossstudy comparisons and model transferability across institutions. Clinical implementation of AI is further associated with requirements for data privacy and security, cyber-resilience, model transparency, and regulatory accountability.